TREACE MEDICAL CONCEPTS, INC. director just disposed of 50,000 shares

James T Treace, a director of TREACE MEDICAL CONCEPTS, INC., recently disposed of 50,000 shares of the company. The disposals took place at prices ranging from $17.37 to $19.39 per share, on dates ranging from November 22 to November 24, 2021. Treace still owns 3,159,204 shares of the company. Treace operates out of Ponte Vedra, FL. Some additional info was provided as follows:


Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.13 to $19.09 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commiss ion, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.32 to $19.54 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.04 to $17.66 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.21 to $18.50 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.12 to $18.0750 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever TREACE MEDICAL CONCEPTS, INC. makes a similar move, sign up!

Other recent filings from the company include the following:

SVP of TREACE MEDICAL CONCEPTS, INC. just cashed-in 47,700 options - Jan. 12, 2022
Treace Medical Concepts Provides 2021 Preliminary Sales Results - Jan. 12, 2022
CIBC Private Wealth Group, LLC just provided an update on share ownership of TREACE MEDICAL CONCEPTS, INC. - Jan. 7, 2022
SVP of TREACE MEDICAL CONCEPTS, INC. just cashed-in 2,300 options - Jan. 5, 2022
Major owner of TREACE MEDICAL CONCEPTS, INC. just disposed of 22,835 shares - Dec. 30, 2021

Auto Refresh

Feedback